Get the Stockscreener App
1.04
1.96%
0.02
After Hours:
1.04
Lexaria Bioscience Corp stock is traded at $1.04, with a volume of 239.49K.
It is up +1.96% in the last 24 hours and up +18.34% over the past month.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.
See More
Previous Close:
$1.02
Open:
$1.03
24h Volume:
239.49K
Relative Volume:
0.55
Market Cap:
$20.34M
Revenue:
$411.00K
Net Income/Loss:
$-4.85M
P/E Ratio:
-2.3636
EPS:
-0.44
Net Cash Flow:
$-4.88M
1W Performance:
+4.00%
1M Performance:
+18.34%
6M Performance:
-12.61%
1Y Performance:
-55.17%
1-Day Range:
$0.9901
$1.05
1-Week Range:
$0.93
$1.05
52-Week Range:
$0.7749
$2.8499
Lexaria Bioscience Corp Stock (LEXX) Company Profile
Name
Lexaria Bioscience Corp
Sector
Industry
Phone
250-765-6424
Address
100 - 740 MCCURDY ROAD, KELOWNA
Compare LEXX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LEXX
Lexaria Bioscience Corp
|
1.04 | 22.67M | 411.00K | -4.85M | -4.88M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Lexaria Bioscience Corp Stock (LEXX) Latest News
Chart overlay techniques for tracking Lexaria Bioscience Corp.Market Risk Analysis & Consistent Return Strategy Ideas - newser.com
Technical signs of recovery in Lexaria Bioscience Corp. Equity WarrantJuly 2025 Patterns & Verified Technical Signals - newser.com
Can volume confirm reversal in Lexaria Bioscience Corp.July 2025 Levels & Expert Verified Movement Alerts - newser.com
How institutional buying supports Lexaria Bioscience Corp. stockJuly 2025 Review & Weekly Stock Performance Updates - newser.com
How to recover losses in Lexaria Bioscience Corp. Equity Warrant stockTrade Signal Summary & Daily Technical Forecast Reports - newser.com
Will Lexaria Bioscience Corp. stock maintain momentum in 2025 - newser.com
Published on: 2025-11-03 06:26:07 - newser.com
Analyzing Lexaria Bioscience Corp. Equity Warrant with risk reward ratio charts2025 Retail Activity & Long-Term Safe Investment Plans - newser.com
Understanding Lexaria Bioscience Corp. Equity Warrant’s price movementWeekly Risk Summary & Smart Allocation Stock Reports - newser.com
What indicators show strength in Lexaria Bioscience Corp.2025 Trading Recap & AI Driven Price Predictions - newser.com
How to escape a deep drawdown in Lexaria Bioscience Corp. Equity WarrantJuly 2025 Short Interest & Weekly Return Optimization Alerts - newser.com
Has Lexaria Bioscience Corp. found a price floorOil Prices & Target Return Focused Stock Picks - newser.com
Historical volatility pattern of Lexaria Bioscience Corp. Equity Warrant visualizedTrade Signal Summary & Free Safe Capital Growth Stock Tips - newser.com
What catalysts could drive Lexaria Bioscience Corp. stock higherWeekly Trade Recap & Fast Entry High Yield Tips - newser.com
Chart based exit strategy for Lexaria Bioscience Corp.2025 Price Momentum & Risk Controlled Daily Trade Plans - newser.com
Is Lexaria Bioscience Corp. stock supported by innovation pipelineQuarterly Portfolio Report & Stepwise Trade Signal Implementation - newser.com
Key metrics from Lexaria Bioscience Corp.’s quarterly dataAnalyst Upgrade & Breakout Confirmation Alerts - newser.com
Intraday pattern recognizer results for Lexaria Bioscience Corp. Equity WarrantLong Setup & Fast Momentum Entry Tips - newser.com
Signal strength of Lexaria Bioscience Corp. Equity Warrant stock in tech scannersMarket Trend Report & High Win Rate Trade Alerts - newser.com
Combining machine learning predictions for Lexaria Bioscience Corp. Equity Warrant2025 Stock Rankings & Reliable Trade Execution Plans - newser.com
Is Lexaria Bioscience Corp. forming a reversal patternTrade Entry Summary & Technical Pattern Alert System - newser.com
Is Lexaria Bioscience Corp. stock a contrarian buyJuly 2025 Breakouts & AI Powered Market Trend Analysis - newser.com
Evaluating Lexaria Bioscience Corp. Equity Warrant with trendline analysisTrade Entry Report & Reliable Price Breakout Signals - newser.com
Using Python tools to backtest Lexaria Bioscience Corp. Equity Warrant strategiesCEO Change & Fast Momentum Entry Tips - newser.com
Reversal indicators forming on Lexaria Bioscience Corp. stockEarnings Summary Report & Risk Managed Investment Signals - newser.com
Is Lexaria Bioscience Corp. Equity Warrant stock in correction or buying zoneJuly 2025 Momentum & Entry and Exit Point Strategies - newser.com
Analyzing net buyer seller activity in Lexaria Bioscience Corp. Equity Warrant - newser.com
What analysts say about Lexaria Bioscience Corp stockSupport Level Holds & Breakthrough Investment Results - earlytimes.in
How Lexaria Bioscience Corp. Equity Warrant stock performs after earningsQuarterly Profit Review & Fast Exit and Entry Strategy Plans - newser.com
How to manage a losing position in Lexaria Bioscience Corp. Equity WarrantQuarterly Earnings Report & Real-Time Volume Trigger Notifications - newser.com
Top chart patterns to watch in Lexaria Bioscience Corp. Equity Warrant2025 Market Trends & Real-Time Buy Zone Alerts - newser.com
How Lexaria Bioscience Corp. stock performs in rising dollar environmentTake Profit & Verified Momentum Stock Ideas - newser.com
Published on: 2025-11-01 01:14:05 - newser.com
Lexaria Bioscience Corp Stock (LEXX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):